In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

Research roundtable highlights early detection, biomarkers, interventions ...

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

Dementia is a group of brain disorders that cause a decline in cognitive functions like memory and thinking. While some cognitive decline is a natural part of aging, dementia is an extreme version ...

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

The experimental drug lecanemab shows "potential" as an Alzheimer's disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association ...

A few years ago, my dad was diagnosed with Alzheimer’s disease, just like his older brother and his mum before him. Slowly, his personality began to ebb away. Now, at the age of 75, his cognitive ...

Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...